Vigabatrin use in psychotic epileptic patients: Report of a prospective pilot study

Acta Neurologica Scandinavica

Volumn 99, Issue 3, 1999, Pages 142-146

  Veggiotti, P ^b   De Agostini, G ^a   Muzio, C ^a   Termine, C ^c   Baldi, P L ^a   Ferrari Ginevra, O ^c   Lanzi, G ^c  

^a Paolo VI Rehabilitation Centre   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c NONE

Author keywords

Cognitive evaluation; Forced normalization; Mental retardation; Pervasive developmental disorders; Psychosis; Vigabatrin

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; HALOPERIDOL; PROMAZINE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; AGGRESSIVENESS; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG CONTRAINDICATION; ELECTROENCEPHALOGRAPHY; EMOTIONAL STABILITY; FEMALE; FOCAL EPILEPSY; HUMAN; MALE; PHASE 1 CLINICAL TRIAL; PSYCHOSIS; SIDE EFFECT; STEREOTYPY;

EID: 0033049950     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1999.tb07335.x     Document Type: Article

References (19)

1. 1. SANDER JWAS, HART YM. Vigabatrin and behaviour disturbances. Lancet 1990;335:57.
2. 2. DAM M. Vigabatrin and behaviour disturbances. Lancet 1990;335:605.
3. 3. BETTS T, THOMAS L. Vigabatrin and behaviour disturbances. Lancet 1990;335:605-6.
4. 4. JOHNS SJ. Vigabatrin and behaviour disturbances. Lancet 1990;335:606.
5. 5. BRODIE MJ, MCKEE PJW. Vigabatrin and psychosis. Lancet 1990;335:1279.
6. 6. RING HA, REYNOLDS EH. Vigabatrin and psychosis. Lancet 1990;335:970.
7. 7. ROBINSON MK, RICHENS A, OXLEY R. Vigabatrin and behaviour disturbances. Lancet 1990;335:504.
8. 8. SANDER JWAS, HART YM, TRIMBLE MR, SCHORVON SD. Vigabatrin and psychosis. J Neurol Neurosurg Psychiatry 1991;54:435-9.
9. 9. STAPLES CI, KING MA, BOYLE RS. Acute psychosis after withdrawal of vigabatrin. Med J Aust 1992;156:291.
10. 10. GAIO JM, POLLAK P, HOMMEL M, PERRET J. Clinical and biochemical effects of gamma-vinyl Gaba in tardive dyskinesia. J Neurol Neurosurg Psychiatry 1987;50:1674-8.
11. 11. DULAC O, CHIRON C, LUNA D et al. Vigabatrin in childhood epilepsy. J Child Neurol 1991:6 (Suppl. 2):30-7.
12. 12. VON NEUMANN J. Distribution of the ratio of the mean square successive difference to the variance. Annals of Mathematical Statistics 1941;12:367-95.
13. 13. YOUNG LC. On randomness in ordered sequences. Annals of Mathematical Statistics 1941;12:239-300.
14. 14. TRYON WW. A simplified time-series analysis for evaluating treatment interventions. J Appl Behav Anal 1982;15:423-9.
15. 15. SPEARMAN C. The abilities of man. New York: MacMillan, 1927.
16. 16. VEGGIOTTI P, DE AGOSTINI G, BALDI PL, MUZIO C, LANZI G. Vigabatrin and psychosis: is there a true correlation? Acta Neurol Scand 1997;95:189-90.
17. 17. PITKÄNEN A, YLINEN A, MATILAINEN R et al. Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. Arch Neurol 1993;50:24-9.
18. 18. ULDALL P, ALVING J, GRAM L, HØGENHAVEN H. Vigabatrin in childhood epilepsy: a 5-year follow-up study. Neuropediatrics 1995;26:253-6.
19. 19. FRENCH JA, MOSIER M, WALKER S et al. A double-blind, placebo-controlled study of Vigabatrin three g/day in patients with uncontrolled complex partial seizures. Neurology 1996;46:54-61.